Orthofix International | OFIX - Operating Profit


Orthofix International reported $6.12M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 4.35M 5.31M Sep/2026
Dexcom USD 318.3M 63M Jun/2026
EDAP TMS EUR -7.37M 2.44M Mar/2026
Globus Medical USD 178.23M 224.2M Sep/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 189.8M 60.1M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
J&J USD 6.47B 1B Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Smith & Nephew USD 505M 65M Jun/2026
STAAR Surgical USD 5.46M 4.64M Sep/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -2.37M 11.42M Sep/2026
Teleflex USD -105.77M 178.84M Sep/2026
Veracyte USD 18.02M 5.94M Sep/2026
Zimmer Biomet Holdings USD 341.5M 3.2M Sep/2026